Medicare Enrolled
Dr. Corey Hunter, M.D.
Interventional Pain Medicine Physician · New York, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hunter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hunter?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hunter
Dr. Corey Hunter is an interventional pain medicine physician in New York, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Hunter performed 4,938 Medicare services across 764 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hunter received a total of $527,890 from 36 pharmaceutical and/or device companies across 741 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hunter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 33% volume in NY
$527,890 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,938
Medicare services
Top 33% in NY for interventional pain medicine physician
764
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~274 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
527 | $18 | $428 |
| Anti-nausea injection (ondansetron/Zofran) | 512 | $0 | $21 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
414 | $1 | $21 |
| Contrast dye for imaging, lower concentration | 409 | $0 | $54 |
| COVID-19 viral test, non-CDC A laboratory test to detect the SARS-CoV-2 virus (COVID-19) using any technique and targeting multiple types or subtypes. This specific code is for tests performed by laboratories that are not the CDC. |
391 | $48 | $107 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
379 | $50 | $109 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
352 | $0 | $21 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
306 | $0 | $43 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
261 | $114 | $523 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
241 | $1 | $54 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
153 | $13 | $428 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
151 | $12 | $48 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
136 | $57 | $1,070 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
132 | $17 | $642 |
| Pyridoxine HCl injection, 100 mg An injection of pyridoxine hydrochloride, a form of vitamin B6, administered at a dose of 100 mg. |
125 | $9 | $32 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
91 | $63 | $374 |
| Psychological or neuropsychological test, first 30 minutes Administration of psychological or neuropsychological testing for the first 30 minutes. |
83 | $38 | $86 |
| Clonidine hydrochloride injection, 1 mg An injection containing 1 mg of clonidine hydrochloride. |
63 | $16 | $160 |
| New patient office visit, complex (60-74 min) | 55 | $185 | $1,012 |
| Injection, fentanyl citrate, 0.1 mg | 32 | $1 | $21 |
| Limited ultrasound of joint or extremity A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels. |
31 | $38 | $535 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
26 | $161 | $705 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
20 | $50 | $1,605 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
18 | $273 | $4,066 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
18 | $118 | $4,066 |
| Orthopedic device training, 15 minutes Training on how to use an orthopedic device for the arm, leg, or trunk. The session lasts for 15 minutes. |
12 | $44 | $214 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.1% high complexity
54.6% medium
29.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$527,890
Total received (2018-2024)
Avg $75,413/year across 7 years
Top 1% in NY for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
741
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$282,790 (53.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$194,672 (36.9%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$42,932 (8.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,325 (1.0%)
Other
Charitable contributions, space rental, and other categories
$2,172 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,618
2023
$40,655
2022
$140,011
2021
$75,664
2020
$51,000
2019
$61,163
2018
$154,779
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$4,167
Saluda Medical Americas, Inc.
$253
PAINTEQ LLC
$61
SI-BONE, INC.
$60
Nalu Medical, Inc.
$33
Medtronic, Inc.
$30
TerSera Therapeutics LLC
$14
Top 3 companies account for 97.0% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$306,820
Vertiflex, Inc.
$87,346
Nalu Medical, Inc.
$50,101
MML US, Inc.
$37,363
Saluda Medical Americas, Inc.
$21,943
BIOTRONIK INC.
$9,271
Boston Scientific Corporation
$4,543
BOSTON SCIENTIFIC CORPORATION
$3,042
Medtronic, Inc.
$2,171
Medtronic Vascular, Inc.
$1,194
PAINTEQ LLC
$699
Amgen Inc.
$554
Vertos Medical, Inc.
$526
SPR Therapeutics, Inc
$499
Nuvectra Corporation
$324
Nevro Corp.
$275
Pacira Pharmaceuticals Incorporated
$217
Stryker Corporation
$170
TerSera Therapeutics LLC
$131
Medtronic USA, Inc.
$90
Flowonix Medical Incorporated
$66
Jazz Pharmaceuticals Inc.
$65
Allergan, Inc.
$61
SI-BONE, INC.
$60
PFIZER INC.
$54
ABBVIE INC.
$54
Epimed International, Inc
$43
Avanos Medical
$33
Merit Medical Systems Inc
$31
FIDIA PHARMA USA INC.
$24
DePuy Synthes Sales Inc.
$23
Bioventus LLC
$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
Biohaven Pharmaceutical Holding Company Ltd.
$19
Allergan Inc.
$17
Kaleo, Inc.
$17
Top 3 companies account for 84.2% of all-time payments
Associated products mentioned in payments ›
AXIUM · Aimovig · Algovita · Axium INS DRG IPG · Axium Sheath Braided DRG · BOTOX · Cardiovascular- Research only · Catheters and Needles · ClosureFast · Durolane · ETERNA · EVEREST SPINAL SYSTEM · EXCLAIM · Eon Family of SCS IPGs · Evoke · Evoke SCS · Evzio · Exparel · GENERATOR · HYALGAN · Hymovis · INTELLIS · INTELLIS ADAPTIVESTIM · IONICRF · IonicRF Generator · LYRICA · NT1100 NT2000iX Simplicity · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Disposables and Accessories · Neuromodulation Dspsbls and Accs · Neuromodulation-Research Only · ORTHOVISC · Octrode SCS Leads · PAINTEQ · PRIALT · PROCLAIM · PRODIGY · PROTG · Prialt · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Proclaim XR IPG · Prodigy Family of SCS IPGs · Prometra II · RELISTOR · ReActiv8 · S-Series SCS Leads · SCS IPGs · SCS leads · SPECTRA WAVEWRITER · SPRINT PNS System · SUPERION · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Superion · Superion ISS · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (54%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional pain medicine physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for interventional pain medicine physician in NY.
Geographic Context
Interventional pain medicine physicians within 10 mi
91
Per 100K population
5.6
County median income
$104,553
Nearest hospital
NEW YORK-PRESBYTERIAN HOSPITAL
0.5 mi
0.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hunter is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of NY peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hunter experienced with additional hour of intravenous infusion?
Based on Medicare claims data, Dr. Hunter performed 527 additional hour of intravenous infusion services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hunter receive payments from pharmaceutical companies?
Yes. Dr. Hunter received a total of $527,890 from 36 companies across 741 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hunter's costs compare to other interventional pain medicine physicians in New York?
Dr. Hunter's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hunter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in New York
Browse interventional pain medicine physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in NY
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in NY
Which NY interventional pain medicine physicians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Vertiflex, Inc. Payments to Doctors
See all physicians who received payments from Vertiflex, Inc.
By company
Nalu Medical, Inc. Payments to Doctors
See all physicians who received payments from Nalu Medical, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology